SCHEMBL6867228

SCHEMBL6867228

CN(C)c1nc(NC2CCC(NC(=O)CCC(=O)c3cccs3)CC2)nc2c1CCCC2

nearest known ligand 0.55

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.40
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
ALDH1A1 P00352 2/20 0.39
POLB P06746 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.38
LMNA P02545 1/20 0.38
MAPT P10636 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
MCHR1 Q99705 4/20 0.38
ADRA2A P08913 3/20 0.38
HRH1 P35367 2/20 0.38
HTR2B P41595 2/20 0.38
ADRA1A P35348 1/20 0.38
PARP1 P09874 1/20 0.37
MAPK1 P28482 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6867225 1.00 HPGD (0.40) HPGDNPC1RAB9AALDH1A1POLB
SCHEMBL27652861 0.87 HPGD (0.50) HPGDNPC1RAB9AALDH1A1L3MBTL1
SCHEMBL27652859 0.87 HPGD (0.50) HPGDNPC1RAB9AALDH1A1L3MBTL1
SCHEMBL6872301 0.85 CYP3A4 (0.46) NPC1RAB9AALDH1A1POLBL3MBTL1
SCHEMBL6872308 0.85 CYP3A4 (0.46) NPC1RAB9AALDH1A1POLBL3MBTL1
SCHEMBL6867296 0.85 MAPT (0.47) NPC1RAB9AALDH1A1POLBLMNA
SCHEMBL6867305 0.85 MAPT (0.47) NPC1RAB9AALDH1A1POLBLMNA
SCHEMBL13793345 0.83 MCHR1 (0.57) HPGDL3MBTL1MCHR1ADRA2AHRH1
SCHEMBL6461821 0.82 MCHR1 (0.52) ALDH1A1MCHR1ADRA2AHRH1HTR2B
SCHEMBL6461823 0.82 MCHR1 (0.52) ALDH1A1MCHR1ADRA2AHRH1HTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100451004-C Pyrimidine derivatives ARENA PHARM INC (JP) 2009-01-14 CN disclosed
CN-1798736-A Novel quinoline, tetrahydroquinazoline and pyrimidine derivatives and methods of treatment related to their use ARENA PHARM INC (JP) 2006-07-05 CN disclosed
EP-1464335-A2 Quinoline, tetrahydroquinoline and pyrimidine derivatives as mch antagonist Taisho Pharmaceutical Co. Ltd. (JP) 2004-10-06 EP disclosed